✦ LIBER ✦

Cost-Effectiveness of Adjuvant FOLFOX Therapy for Stage III Colon Cancer in Japan Based on the MOSAIC Trial

✍ Scribed by Takeru Shiroiwa; Toshihiro Takeuchi; Takashi Fukuda; Kojiro Shimozuma; Yasuo Ohashi

Book ID: 119310846
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 777 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN80 COST-EFFECTIVENESS ANALYSIS OF OXL

PCN80 COST-EFFECTIVENESS ANALYSIS OF OXLIPLATIN IN ADJUVANT THERAPY FOR STAGE 3 COLON CANCER PATIENTS IN JAPAN

✍ T Fukuda; T Shiroiwa; T Takeuchi; K Shimozuma; Y Ohashi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN39 EXPLORATORY COST EFFECTIVENESS ANA

PCN39 EXPLORATORY COST EFFECTIVENESS ANALYSIS OF BEVACIZUMAB IN ADDITION TO FOLFOX-4 IN THE ADJUVANT TREATMENT OF STAGE III COLON CANCER: A UK PERSPECTIVE

✍ P Ducournau; N Latimer; E Sabate; S Walzer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Prognostic Impact of Deficient DNA Misma

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

✍ Sinicrope, F. A.; Mahoney, M. R.; Smyrk, T. C.; Thibodeau, S. N.; Warren, R. S.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 240 KB

Safety of UFT/LV and S-1 as adjuvant the

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

✍ Mochizuki, I; Takiuchi, H; Ikejiri, K; Nakamoto, Y; Kinugasa, Y; Takagane, A; En 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 302 KB

3600 POSTER Costs of Adjuvant Chemothera

3600 POSTER Costs of Adjuvant Chemotherapy With Oxaliplatin in Stage III Colon Cancer – Comparing the Three Schemes Standards: FOLFOX-4, FLOX and XELOX

✍ G. Calderillo Ruiz; J. Melchor; E. Ruiz; A. Herrera; A. Meneses; A. Albarran 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

PCN96 Costs of Adjuvant Chemotherapy wit

PCN96 Costs of Adjuvant Chemotherapy with Oxaliplatin in Stage III Colon Cancer: Comparing the Three Schemes Standards: FOLFOX-4, FLOX and XELOX

✍ Calderillo, G.; Melchor, J.; Ruiz, E.; Meneses, A.; Albarran, A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB